JPS54154787A - Cephalosporanic compound - Google Patents
Cephalosporanic compoundInfo
- Publication number
- JPS54154787A JPS54154787A JP6669679A JP6669679A JPS54154787A JP S54154787 A JPS54154787 A JP S54154787A JP 6669679 A JP6669679 A JP 6669679A JP 6669679 A JP6669679 A JP 6669679A JP S54154787 A JPS54154787 A JP S54154787A
- Authority
- JP
- Japan
- Prior art keywords
- cephalosporanic
- compound
- cephalosporanic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB23041/78A GB1604723A (en) | 1978-05-26 | 1978-05-26 | 7-(2-aminothiazol-4-yl)-2-oxyimino-acetamido)-cephem derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS54154787A true JPS54154787A (en) | 1979-12-06 |
Family
ID=10189150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6669679A Pending JPS54154787A (en) | 1978-05-26 | 1979-05-25 | Cephalosporanic compound |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS54154787A (ja) |
KR (1) | KR830001130B1 (ja) |
BE (1) | BE876539A (ja) |
GB (1) | GB1604723A (ja) |
ZA (1) | ZA792582B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60178890A (ja) * | 1984-02-23 | 1985-09-12 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン誘導体およびその製造法 |
JPS6117589A (ja) * | 1984-07-03 | 1986-01-25 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン誘導体及びその製造法 |
JPS63152388A (ja) * | 1979-11-19 | 1988-06-24 | Fujisawa Pharmaceut Co Ltd | 新規なセフェム化合物 |
JPH0327388A (ja) * | 1989-05-11 | 1991-02-05 | Lucky Co Ltd | 新規のセファロスポリン化合物およびその製造方法 |
JPH04217987A (ja) * | 1990-03-24 | 1992-08-07 | Lucky Co Ltd | セファロスポリン、中間体および製法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2516515A1 (fr) * | 1981-11-16 | 1983-05-20 | Sanofi Sa | Nouveaux derives de pyridinium thiomethyl cephalosporines, procede pour leur preparation et compositions pharmaceutiques les contenant |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52125190A (en) * | 1976-04-12 | 1977-10-20 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acids, their salts and their preparation |
-
1978
- 1978-05-26 GB GB23041/78A patent/GB1604723A/en not_active Expired
-
1979
- 1979-02-25 BE BE0/195382A patent/BE876539A/xx not_active IP Right Cessation
- 1979-05-25 JP JP6669679A patent/JPS54154787A/ja active Pending
- 1979-05-25 ZA ZA792582A patent/ZA792582B/xx unknown
- 1979-05-25 KR KR1019790001688A patent/KR830001130B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52125190A (en) * | 1976-04-12 | 1977-10-20 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acids, their salts and their preparation |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63152388A (ja) * | 1979-11-19 | 1988-06-24 | Fujisawa Pharmaceut Co Ltd | 新規なセフェム化合物 |
JPH0369353B2 (ja) * | 1979-11-19 | 1991-10-31 | Fujisawa Pharmaceutical Co | |
JPS60178890A (ja) * | 1984-02-23 | 1985-09-12 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン誘導体およびその製造法 |
JPH0521912B2 (ja) * | 1984-02-23 | 1993-03-25 | Meiji Seika Kk | |
JPS6117589A (ja) * | 1984-07-03 | 1986-01-25 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン誘導体及びその製造法 |
JPH0522719B2 (ja) * | 1984-07-03 | 1993-03-30 | Meiji Seika Kk | |
JPH0327388A (ja) * | 1989-05-11 | 1991-02-05 | Lucky Co Ltd | 新規のセファロスポリン化合物およびその製造方法 |
JPH04217987A (ja) * | 1990-03-24 | 1992-08-07 | Lucky Co Ltd | セファロスポリン、中間体および製法 |
Also Published As
Publication number | Publication date |
---|---|
BE876539A (fr) | 1979-11-26 |
KR830001130B1 (ko) | 1983-06-14 |
KR830000698A (ko) | 1983-04-18 |
ZA792582B (en) | 1980-07-30 |
GB1604723A (en) | 1981-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS54119486A (en) | 66substituted thiaaaza compound | |
JPS5592393A (en) | Aminoorganosiliconacylamino compound | |
JPS54154786A (en) | Cephalosporin compound | |
GB2025999B (en) | Bistrialkoxysiloxy - silane compound | |
GB2031425B (en) | 3-unsubstituted-3-cephem compounds | |
JPS54163582A (en) | 22phenoxyy55 trifluoromethypiridine compound | |
JPS54138524A (en) | Boronnsilicon compound | |
JPS54160397A (en) | Antiirhinouiruse compound | |
GB2020279B (en) | Piperazinylbenzoheterocyclic compounds | |
GB2036724B (en) | Cephalosporin compounds | |
JPS54138522A (en) | Sulfonateeorganosilanol compound | |
JPS54125625A (en) | 33hydroxybenzyl compound | |
JPS54128538A (en) | 44nitroo22trichlormethyllphenyldisulfide compound | |
JPS54141766A (en) | Antiiinflammatory compound | |
JPS5536471A (en) | Spiroketaline compound | |
JPS5559193A (en) | Bblactam compound | |
JPS54154787A (en) | Cephalosporanic compound | |
JPS554400A (en) | Hindereddphenol compound | |
JPS5553271A (en) | Novel acylaminoo1*44dihydropyridine compound | |
ZA791653B (en) | Cephalosporin compounds | |
JPS5566589A (en) | Aminothiazole compound | |
GB2018764B (en) | Cephalosporin compounds | |
GB2039890B (en) | Cephem compounds | |
JPS54151989A (en) | 44pyrimidylsulfide compound | |
JPS5559197A (en) | Novel cephalosporin compound |